Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -5.48% vs 12.70% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -17.71% vs -12.73% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.70",
          "val2": "62.10",
          "chgp": "-5.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.10",
          "val2": "13.30",
          "chgp": "-54.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.90",
          "val2": "9.60",
          "chgp": "-17.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "103.20%",
          "val2": "132.30%",
          "chgp": "-2.91%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.93% vs -11.60% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -20.20% vs 24.08% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "254.40",
          "val2": "223.30",
          "chgp": "13.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.00",
          "val2": "42.30",
          "chgp": "34.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.70",
          "val2": "3.10",
          "chgp": "-77.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.30",
          "val2": "50.50",
          "chgp": "-20.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "135.60%",
          "val2": "106.00%",
          "chgp": "2.96%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

58.70

62.10

-5.48%

Operating Profit (PBDIT) excl Other Income

6.10

13.30

-54.14%

Interest

0.10

0.00

Exceptional Items

0.00

0.30

-100.00%

Consolidate Net Profit

7.90

9.60

-17.71%

Operating Profit Margin (Excl OI)

103.20%

132.30%

-2.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is -5.48% vs 12.70% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -17.71% vs -12.73% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

254.40

223.30

13.93%

Operating Profit (PBDIT) excl Other Income

57.00

42.30

34.75%

Interest

0.10

0.10

Exceptional Items

0.70

3.10

-77.42%

Consolidate Net Profit

40.30

50.50

-20.20%

Operating Profit Margin (Excl OI)

135.60%

106.00%

2.96%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 13.93% vs -11.60% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -20.20% vs 24.08% in Dec 2023

All Annual Results